专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2005107722A2 DIRECTLY COMPRESSIBLE TRICALCIUM PHOSPHATE 审中-公开
标题翻译：直接耐压磷酸三钙
公开(公告)号：WO2005107722A2
公开(公告)日：2005-11-17
申请号：PCT/US2005/015385
申请日：2005-05-04
申请人： RHODIA INC.
发明人： HENDRICKS, Lewis, Roe , JOBBINS, Jill, Marie , CAMARCO, Wayne
IPC分类号： A61K9/68
CPC分类号： A61K9/2027 , A61K9/0056 , A61K9/2009 , A61K9/205 , A61K9/2054 , A61K9/2095 , A61K33/06 , A61K33/42 , Y10S514/951 , Y10S514/952 , Y10S514/96
摘要： A compressible tricalcium phosphate agglomerate comprises tricalcium phosphate particles, each having an outer surface, and a binder comprising a polyvinylpyrollidone, carageenan, or a guar gum, supported on at least a portion of the outer surface of at least a portion of the tricalcium phosphate particles.
摘要翻译：可压缩的磷酸钙聚集体包括磷酸三钙颗粒，每个具有外表面，和包含聚乙烯吡咯烷酮，角叉菜胶或瓜尔胶的粘合剂，其负载在磷酸三钙颗粒的至少一部分的外表面的至少一部分上。

2. 发明申请

WO02053068A1 CALCIUM PHOSPHATE COMPOSITION AND METHOD OF PREPARING SAME 审中-公开
标题翻译：磷酸钙组合物及其制备方法
公开(公告)号：WO02053068A1
公开(公告)日：2002-07-11
申请号：PCT/US2001/050218
申请日：2001-12-20
IPC分类号： A61F2/00 , A61F2/28 , A61F2/46 , A61L27/12
CPC分类号： A61L27/12 , A61F2/28 , A61F2002/4631 , A61F2310/00293 , Y10S514/951 , Y10S514/952
摘要： A method for controlling the formation of a hydroxyapatite bone filler from dry calcium phosphate precursors in an aqueous solution uses coated sodium phosphate powder. The sodium phosphate powder is coated with a water soluble cellulose. Until the calcium dissolves in the aqueous solution setting of the cellulose phosphate cements proceeds slowly but when the exposed sodium phosphate particles start to solubilize in the aqueous solution the setting rate increases.
摘要翻译：用于控制水溶液中干磷酸钙前体形成羟基磷灰石骨填料的方法使用涂覆的磷酸钠粉末。磷酸钠粉末涂有水溶性纤维素。直到钙溶解在纤维素磷酸盐水泥的水溶液中才缓慢进行，但是当暴露的磷酸钠颗粒开始溶解在水溶液中时，凝固速率增加。

3. 发明申请

WO99051096A1 PULMONARY AND NASAL DELIVERY OF RALOXIFENE 审中-公开
标题翻译：拉莫昔芬的脉冲和鼻腔递送
公开(公告)号：WO99051096A1
公开(公告)日：1999-10-14
申请号：PCT/US1999/007184
申请日：1999-03-31
IPC分类号： A61K9/00 , A61K9/12 , A61K9/72 , A61K31/4535 , A61P19/10 , A01N43/40
CPC分类号： A61K9/0078 , A61K9/0043 , A61K9/0073 , A61K9/008 , A61K31/4535 , Y10S514/874 , Y10S514/951 , Y10S514/952 , Y10S514/958
摘要： The present invention relates to formulations and methods for pulmonary and nasal administration of raloxifene.
摘要翻译：本发明涉及用于肺和鼻内给予雷洛昔芬的制剂和方法。

4. 发明申请

WO99009823A1 DOSAGE DEVICE 审中-公开
标题翻译：剂量装置
公开(公告)号：WO99009823A1
公开(公告)日：1999-03-04
申请号：PCT/GB1998/002521
申请日：1998-08-21
IPC分类号： A01N25/04 , A01N25/34 , A01P7/00
CPC分类号： A01N25/34 , Y10S514/937 , Y10S514/951 , Y10S514/952 , Y10S514/96
摘要： A method of making a dosage device comprises mixing a suspension concentrate comprising at least one active ingredient which is in solid form at 25 DEG C, and which has an average particle size of less than 10 microns, in a carrier liquid in which the active ingredient is non-soluble or sparingly soluble, and a drying agent for the carrier liquid. The drying agent takes up at least some of the carrier liquid of the suspension concentrate, thereby to dry the active ingredient at least partly and to obtain a mixture comprising the active ingredient and the drying agent. The mixture is compressed into at least one unitary dosage device.
摘要翻译：制备剂量装置的方法包括在载体液体中混合包含至少一种在25℃下为固体形式且平均粒度小于10微米的活性成分的悬浮浓缩物，其中活性成分是不可溶或微溶的，以及用于载液的干燥剂。干燥剂吸收悬浮浓缩物的至少一些载液，从而至少部分干燥活性成分，并获得包含活性成分和干燥剂的混合物。混合物被压缩成至少一个单位剂量装置。

5. 发明申请

WO1998011878A1 DIRECTLY COMPRESSIBLE LACTITOL AND METHOD 审中-公开
标题翻译：直接耐压的LACTITOL和方法
公开(公告)号：WO1998011878A1
公开(公告)日：1998-03-26
申请号：PCT/FI1997000548
申请日：1997-09-16
申请人： XYROFIN OY , PEARSON, Julita , OLINGER, Philip
发明人： XYROFIN OY
IPC分类号： A61K09/20
CPC分类号： A61K9/2018 , Y10S514/952 , Y10S514/96
摘要： The invention relates to a directly compressible lactitol granulate and lactitol tablets made therefrom. The granulate comprises lactitol and a physiologically acceptable, non-cariogenic binder, which may be a non-cariogenic sugar alcohol, a polymerized reducing sugar, and alkali carboxymethylcellulose, a hydrogenated starch hydrolysate, a hydroxypropylcellulose, a physiologically acceptable cellulose derivative, polyvinylpyrrolidone, gum arabic or another physiologically acceptable gum. The preferred binder is lactitol. The invention also relates to a method of producing a directly compressible lactitol granulate, which can be used in tabletting contexts. The produced tablets exhibit high hardness and low friability. They are non-cariogenic and manifest the taste profile and metabolic properties of lactitol.
摘要翻译：本发明涉及由其制成的直接可压缩的乳糖醇颗粒和乳糖醇片剂。该颗粒包括乳糖醇和生理上可接受的非致龋粘合剂，其可以是非致龋糖醇，聚合的还原糖和碱性羧甲基纤维素，氢化淀粉水解物，羟丙基纤维素，生理学上可接受的纤维素衍生物，聚乙烯吡咯烷酮，胶阿拉伯胶或另一种生理上可接受的胶。优选的粘合剂是乳糖醇。本发明还涉及一种生产直接可压缩的乳糖醇颗粒的方法，其可用于压片上下文。生产的片剂具有高硬度和低脆性。它们是非龋齿的，并且表现出乳糖醇的味道特征和代谢性质。

6. 发明申请

WO1996019200A1 SUSTAINED-RELEASE GRANULAR PREPARATION AND PROCESS FOR PRODUCING THE SAME 审中-公开
标题翻译：可持续发行颗粒制备及其生产方法
公开(公告)号：WO1996019200A1
公开(公告)日：1996-06-27
申请号：PCT/JP1995002594
申请日：1995-12-18
申请人： DAIICHI PHARMACEUTICAL CO., LTD. , NAKAGAMI, Hiroaki , KOJIMA, Masazumi , SAGASAKI, Shinji
发明人： DAIICHI PHARMACEUTICAL CO., LTD.
IPC分类号： A61K09/16
CPC分类号： A61K9/1617 , A61K9/1652 , A61K9/1694 , Y10S514/951 , Y10S514/952
摘要： A sustained-release granular preparation that is excellent in sustained-releasability and highly safe for the human body. It can be produced readily in a simplified manner by wet granulating an aqueous suspension containing a medicinally efficacious ingredient, a particulate polymer having an average particle diameter of 50 mu m or less, and a plasticizer, and treating the obtained granules at a temperature which ever is lower between the lowest film-forming temperature of a mixture of the polymer and the plasticizer and the glass transition temperature thereof.
摘要翻译：持续释放性优异且对人体高度安全的缓释颗粒剂。通过湿法造粒含有药用有效成分的水性悬浮液，平均粒径为50μm以下的粒状聚合物和增塑剂，可以容易地制造，并且在所得到的颗粒的温度下进行处理在聚合物和增塑剂的混合物的最低成膜温度和玻璃化转变温度之间较低。

7. 发明申请

WO1996018389A1 SUSTAINED RELEASE CAFFEINE FORMULATION 审中-公开
标题翻译：持续释放CAFFEINE制剂
公开(公告)号：WO1996018389A1
公开(公告)日：1996-06-20
申请号：PCT/IB1995001056
申请日：1995-11-27
申请人： SOCIETE DES PRODUITS NESTLE SA
发明人： SOCIETE DES PRODUITS NESTLE SA , CHAUFFARD, Françoise , ENSLEN, Marc, Y., A. , TACHON, Pierre
IPC分类号： A61K09/50
CPC分类号： A61K31/52 , A61K9/5078 , Y10S514/952
摘要： The present invention relates to a composition for the controlled release of a stimulant of xanthine or a xanthine derivative, which comprises microparticles including a biodegradable matrix of at least one water-soluble material and the stimulant, said stimulant being in the form of solid particles which are substantially uniformly distributed throughout the matrix. It is also concerning a method for making this composition by dispersing the stimulant in the form of a plurality of solid particles into a biodegradable matrix. Such composition can advantageously be orally administrated for increasing the alertness of an individual.
摘要翻译：本发明涉及用于控制释放黄嘌呤或黄嘌呤衍生物刺激剂的组合物，其包含包含至少一种水溶性物质的生物可降解基质和刺激剂的微粒，所述刺激剂为固体颗粒形式基本上均匀地分布在整个基质中。还涉及通过将多种固体颗粒形式的刺激剂分散到可生物降解的基质中来制备该组合物的方法。这种组合物可以有利地口服给药以增加个体的警觉性。

8. 发明申请

WO1995005161A1 HYDROGEL-BASED MICROSPHERE DRUG DELIVERY SYSTEMS 审中-公开
标题翻译：基于氢键的微胶囊药物输送系统
公开(公告)号：WO1995005161A1
公开(公告)日：1995-02-23
申请号：PCT/US1994008319
申请日：1994-08-11
申请人： VITAPHORE CORPORATION
发明人： VITAPHORE CORPORATION , OTTOBONI, Thomas, B. , JUNGHERR, Lisa, B. , YAMAMOTO, Ronald, K.
IPC分类号： A61K09/00
CPC分类号： A61K9/1635 , A61K9/0048 , A61K9/1658 , Y10S514/912 , Y10S514/913 , Y10S514/914 , Y10S514/952
摘要： The present invention provides a sustained-release delivery composition for ophthalmic drugs comprising hydrogel microspheres having a binding affinity for the drug.
摘要翻译：本发明提供了一种用于眼科药物的持续释放递送组合物，其包含对药物具有结合亲和性的水凝胶微球。

9. 发明申请

WO2008007224A2 FOAMABLE SUSPENSION GEL 审中-公开
标题翻译：可发泡的悬浮凝胶
公开(公告)号：WO2008007224A2
公开(公告)日：2008-01-17
申请号：PCT/IB2007/002958
申请日：2007-03-29
申请人： CONNETICS AUSTRALIA PTY LTD , ABRAM, Albert, Zorko , FUCHSHUBER, Lilian
发明人： ABRAM, Albert, Zorko , FUCHSHUBER, Lilian
CPC分类号： A61K9/122 , A61K9/0014 , A61K9/06 , A61K31/192 , A61K31/203 , A61K31/327 , A61K31/63 , A61K31/7034 , A61K31/7056 , A61K47/36 , Y10S514/945 , Y10S514/952 , A61K2300/00
摘要： The present subject matter provides foamable suspension gels that foam after release from a container. The foamable suspension gels contain at least one pharmaceutically active agent that is sparingly soluble to insoluble in water, a second pharmaceutically active agent, and optionally a third active agent.
摘要翻译：本发明主题提供了从容器释放后起泡的可发泡悬浮凝胶。可发泡的悬浮凝胶含有至少一种微溶于难溶于水的药物活性剂，第二药物活性剂和任选的第三活性剂。

10. 发明申请

WO2003045151A1 A PESTICIDE COMPOSITION CONTAINING FINELY GROUND AMORPHOUS SILICA 审中-公开
标题翻译：含有精细接地非晶硅的农药组合物
公开(公告)号：WO2003045151A1
公开(公告)日：2003-06-05
申请号：PCT/AU2002/001582
申请日：2002-11-22
申请人： GEM OF THE NORTH PTY LTD
发明人： GUERASSIMOFF, Jules
IPC分类号： A01N59/00
CPC分类号： A01N59/00 , Y02A50/359 , Y10S514/875 , Y10S514/937 , Y10S514/951 , Y10S514/952 , A01N25/04 , A01N2300/00
摘要： A pesticide composition contains a suspension of finely milled a morphous silica in water and optionally containing other ingredients. The composition can be sprayed onto a pest and/or the pest habitat to control the pest. The composition can control insects, flies, external and internal animal parasites, fungal organisms, worms, larvae and the like. The amorphous silica provides silica in a plant available format which provides an added benefit.
摘要翻译：农药组合物含有细碎的二氧化硅在水中并任选地含有其它成分的悬浮液。可以将组合物喷洒到害虫和/或害虫栖息地上以控制害虫。组合物可以控制昆虫，苍蝇，外部和内部动物寄生虫，真菌生物，蠕虫，幼虫等。无定形二氧化硅以植物可用的形式提供二氧化硅，这提供了附加的益处。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式